Table 1

Baseline clinical characteristics for the ABT-116, carprofen, tramadol, and placebo treatment groups
ABT-116 Carprofen Tramadol Placebo
(n = 13) (n = 12) (n = 12) (n = 12)
Body weight (kg) 34.9 ± 6.0 34.2 ± 6.9 34.9 ± 9.9 34.0 ± 8.4
Age (years) 6.0 ± 4.1 8.6 ± 3.6 9.2 ± 3.2 9.5 ± 4.2
Gender SF – 8 SF – 6 SF – 7 SF – 8
NM - 5 NM - 6 F - 1 NM – 3
NM - 4 M - 1
Clinical Severity 2 (1, 3) 1.5 (1, 3) 2, (1, 3) 2 (1, 3)

Note: All values represent mean ± standard deviation, except for clinical severity, which is reported as median (range). n – sample number. SF – ovariohysterectomized female; F – female; NM – castrated male; M – male. At the start of the trial (Day 1), dogs were graded for clinical severity of lameness and pain (normal – 0; mild – 1; moderate −2; and severe - 3), and orthopaedic physical examination was performed.

Malek et al.

Malek et al. BMC Veterinary Research 2012 8:185   doi:10.1186/1746-6148-8-185

Open Data